1. Home
  2. EQH vs ABVX Comparison

EQH vs ABVX Comparison

Compare EQH & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equitable Holdings Inc.

EQH

Equitable Holdings Inc.

HOLD

Current Price

$41.26

Market Cap

11.7B

Sector

Finance

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$121.83

Market Cap

9.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQH
ABVX
Founded
1859
2013
Country
United States
France
Employees
8000
67
Industry
Specialty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
9.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EQH
ABVX
Price
$41.26
$121.83
Analyst Decision
Buy
Buy
Analyst Count
11
13
Target Price
$56.82
$131.31
AVG Volume (30 Days)
3.7M
791.7K
Earning Date
05-04-2026
03-23-2026
Dividend Yield
2.60%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$43.13
$52.14
Revenue Next Year
$7.45
$4,132.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.20
$5.59
52 Week High
$56.61
$148.83

Technical Indicators

Market Signals
Indicator
EQH
ABVX
Relative Strength Index (RSI) 50.73 54.75
Support Level $36.49 $107.29
Resistance Level $44.17 $129.73
Average True Range (ATR) 1.36 4.91
MACD -0.21 0.71
Stochastic Oscillator 34.39 70.49

Price Performance

Historical Comparison
EQH
ABVX

About EQH Equitable Holdings Inc.

Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: